<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Frasse PM</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NSERC</funding><funding>NICHD NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Burroughs Wellcome Fund</funding><funding>National Institutes of Health</funding><funding>CIHR ICR</funding><funding>Canadian Institutes of Health Research</funding><funding>CIHR</funding><pagination>101550</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8808168</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>298(2)</volume><pubmed_abstract>The malaria-causing parasite Plasmodium falciparum is responsible for over 200 million infections and 400,000 deaths per year. At multiple stages during its complex life cycle, P. falciparum expresses several essential proteins tethered to its surface by glycosylphosphatidylinositol (GPI) anchors, which are critical for biological processes such as parasite egress and reinvasion of host red blood cells. Targeting this pathway therapeutically has the potential to broadly impact parasite development across several life stages. Here, we characterize an upstream component of parasite GPI anchor biosynthesis, the putative phosphomannomutase (PMM) (EC 5.4.2.8), HAD5 (PF3D7_1017400). We confirmed the PMM and phosphoglucomutase activities of purified recombinant HAD5 by developing novel linked enz</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria-causing parasites.</pubmed_title><pmcid>PMC8808168</pmcid><funding_grant_id>R21 AI144472</funding_grant_id><funding_grant_id>R61 HD105594</funding_grant_id><funding_grant_id>R21 AI123808</funding_grant_id><funding_grant_id>153332</funding_grant_id><funding_grant_id>R01 AI103280</funding_grant_id><funding_grant_id>R61 DH105594</funding_grant_id><funding_grant_id>R21 AI130584</funding_grant_id><funding_grant_id>03893-2020</funding_grant_id><pubmed_authors>Zhu JS</pubmed_authors><pubmed_authors>Goldberg DE</pubmed_authors><pubmed_authors>Odom John AR</pubmed_authors><pubmed_authors>Frasse PM</pubmed_authors><pubmed_authors>Soleimani E</pubmed_authors><pubmed_authors>Miller JJ</pubmed_authors><pubmed_authors>Polino AJ</pubmed_authors><pubmed_authors>Jez JM</pubmed_authors><pubmed_authors>Jakeman DL</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enzymatic and structural characterization of HAD5, an essential phosphomannomutase of malaria-causing parasites.</name><description>The malaria-causing parasite Plasmodium falciparum is responsible for over 200 million infections and 400,000 deaths per year. At multiple stages during its complex life cycle, P. falciparum expresses several essential proteins tethered to its surface by glycosylphosphatidylinositol (GPI) anchors, which are critical for biological processes such as parasite egress and reinvasion of host red blood cells. Targeting this pathway therapeutically has the potential to broadly impact parasite development across several life stages. Here, we characterize an upstream component of parasite GPI anchor biosynthesis, the putative phosphomannomutase (PMM) (EC 5.4.2.8), HAD5 (PF3D7_1017400). We confirmed the PMM and phosphoglucomutase activities of purified recombinant HAD5 by developing novel linked enz</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-05-30T15:17:03.186Z</modification><creation>2024-10-18T17:10:12.527Z</creation></dates><accession>S-EPMC8808168</accession><cross_references><pubmed>34973333</pubmed><doi>10.1016/j.jbc.2021.101550</doi></cross_references></HashMap>